Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Whole Genome Sequencing Market: By Technology, By Application, By End User, and Geography
Whole Genome Sequencing Market: By Technology, By Application, By End User, and Geography
Whole Genome Sequencing Market size was valued at US$ 1,829.3 billion in 2023 and is poised to grow at a compound annual growth rate (CAGR) of 17.9% from 2024 to 2030. Whole genome sequencing (WGS) is a comprehensive method for analyzing entire genomes, providing detailed information about an organism's DNA. This market encompasses various products and services essential for genomic analysis, including sequencing instruments, reagents, and bioinformatics solutions. The WGS market serves a diverse range of applications, from basic research to clinical diagnostics and drug development. Its applications span across oncology, rare diseases, infectious diseases, and agricultural genomics, addressing the growing demand for precision medicine and personalized healthcare solutions.
The growth of the WGS market is driven by factors such as declining sequencing costs, increasing prevalence of genetic disorders, and growing adoption of genomic medicine. For instance, the National Human Genome Research Institute reports that the cost of sequencing a human genome has dropped from about $100 million in 2001 to less than $1,000 in 2020. Moreover, the COVID-19 pandemic has accelerated the adoption of genomic technologies for pathogen surveillance and vaccine development, further boosting market expansion. However, challenges such as data interpretation complexity and ethical concerns regarding genetic information may impact market growth to some extent.
Study Period
2024-2030Base Year
2023CAGR
17.9%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The increasing focus on personalized medicine and the growing understanding of genetic contributions to diseases have intensified the demand for comprehensive genomic analysis tools. WGS offers several advantages over targeted sequencing approaches, including the ability to detect novel variants and complex structural changes. These factors contribute to the expanding adoption of WGS across research and clinical settings. Furthermore, technological advancements in sequencing chemistries, sample preparation methods, and bioinformatics have enhanced the speed, accuracy, and cost-effectiveness of WGS. The development of long-read sequencing technologies and improved algorithms for data analysis has addressed many historical challenges associated with genome assembly and variant detection. Additionally, the integration of artificial intelligence and machine learning in genomic data interpretation is opening new possibilities for understanding complex genetic traits and diseases. This trend has been further accelerated by large-scale genomic initiatives worldwide, such as the UK Biobank and the All of Us Research Program in the United States, which are generating vast amounts of genomic data and driving innovation in the field.
Based on regions the whole genome sequencing market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. In 2023, North America accounted for the largest revenue share in the WGS market, estimated at 40%. The region's dominance is attributed to significant investments in genomics research, the presence of major biotechnology companies, and early adoption of precision medicine approaches. The United States, in particular, leads in WGS applications, supported by initiatives like the NIH's Genome Research to Elucidate the Genetics of Rare Diseases (GREGoR) program. Europe holds the second-largest market share, driven by strong government support for genomic medicine and the presence of leading research institutions. The Asia-Pacific region is expected to witness the most rapid growth in the WGS market, with a significant CAGR during the forecast period. This expansion is fueled by increasing investment in healthcare infrastructure, growing awareness of genetic diseases, and rising adoption of advanced diagnostic technologies. Countries like China and Japan are investing heavily in large-scale genome sequencing projects, driving the demand for WGS technologies and services.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 1,829.3 billion |
|
Market CAGR |
17.9% |
|
By Technology |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global whole genome sequencing market size was valued at US$ 1,829.3 billion in 2023 and is projected to grow at a CAGR of 17.9% from 2024- 2030.
The leading players in the global whole genome sequencing market include Illumina, Inc., Thermo Fisher Scientific Inc., BGI Group, Pacific Biosciences of California, Inc., and Oxford Nanopore Technologies plc, among others.
The expansion of the WGS market is driven by declining sequencing costs, increasing adoption of precision medicine, growing prevalence of genetic disorders, and technological advancements in sequencing and bioinformatics.
Challenges in data interpretation, ethical concerns regarding genetic information, and the need for specialized expertise may hamper the global whole genome sequencing market. High initial costs and limited reimbursement policies in some regions may also hinder market growth.
| 1.Executive Summary |
| 2.Global Whole Genome Sequencing Market Introduction |
| 2.1.Global Whole Genome Sequencing Market - Taxonomy |
| 2.2.Global Whole Genome Sequencing Market - Definitions |
| 2.2.1.Technology |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Whole Genome Sequencing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Whole Genome Sequencing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Whole Genome Sequencing Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Sequencing by Synthesis |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Ion Semiconductor Sequencing |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Nanopore Sequencing |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Whole Genome Sequencing Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Diagnostics |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Drug Discovery and Development |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Personalized Medicine |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Whole Genome Sequencing Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Academic & Research Institutes |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Pharmaceutical & Biotechnology Companies |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Hospitals & Clinics |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Whole Genome Sequencing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Whole Genome Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Sequencing by Synthesis |
| 9.1.2.Ion Semiconductor Sequencing |
| 9.1.3.Nanopore Sequencing |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Diagnostics |
| 9.2.2.Drug Discovery and Development |
| 9.2.3.Personalized Medicine |
| 9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Academic & Research Institutes |
| 9.3.2.Pharmaceutical & Biotechnology Companies |
| 9.3.3.Hospitals & Clinics |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Whole Genome Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Sequencing by Synthesis |
| 10.1.2.Ion Semiconductor Sequencing |
| 10.1.3.Nanopore Sequencing |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Diagnostics |
| 10.2.2.Drug Discovery and Development |
| 10.2.3.Personalized Medicine |
| 10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Academic & Research Institutes |
| 10.3.2.Pharmaceutical & Biotechnology Companies |
| 10.3.3.Hospitals & Clinics |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Whole Genome Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Sequencing by Synthesis |
| 11.1.2.Ion Semiconductor Sequencing |
| 11.1.3.Nanopore Sequencing |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Diagnostics |
| 11.2.2.Drug Discovery and Development |
| 11.2.3.Personalized Medicine |
| 11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Academic & Research Institutes |
| 11.3.2.Pharmaceutical & Biotechnology Companies |
| 11.3.3.Hospitals & Clinics |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Whole Genome Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Sequencing by Synthesis |
| 12.1.2.Ion Semiconductor Sequencing |
| 12.1.3.Nanopore Sequencing |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Diagnostics |
| 12.2.2.Drug Discovery and Development |
| 12.2.3.Personalized Medicine |
| 12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Academic & Research Institutes |
| 12.3.2.Pharmaceutical & Biotechnology Companies |
| 12.3.3.Hospitals & Clinics |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Whole Genome Sequencing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Sequencing by Synthesis |
| 13.1.2.Ion Semiconductor Sequencing |
| 13.1.3.Nanopore Sequencing |
| 13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Diagnostics |
| 13.2.2.Drug Discovery and Development |
| 13.2.3.Personalized Medicine |
| 13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Academic & Research Institutes |
| 13.3.2.Pharmaceutical & Biotechnology Companies |
| 13.3.3.Hospitals & Clinics |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Illumina, Inc. |
| 14.2.2.Thermo Fisher Scientific Inc. |
| 14.2.3.BGI Group |
| 14.2.4.Pacific Biosciences of California, Inc. |
| 14.2.5.Oxford Nanopore Technologies plc |
| 14.2.6.QIAGEN N.V. |
| 14.2.7.Macrogen, Inc. |
| 14.2.8.Novogene Co., Ltd. |
| 14.2.9.Genewiz, Inc. (Brooks Automation, Inc.) |
| 14.2.10.Roche Holding AG |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.